Apimeds Pharmaceuticals US, Inc. announced the immediate resignation of Interim Chief Financial Officer Erick Frim on September 29, 2026, citing no disagreements with company operations. The Board appointed Eric Sherb as Chief Financial Officer and Principal Accounting Officer effective October 1, 2026. Mr. Sherb brings over 18 years of capital markets experience and previously served as a fractional CFO for the Company's subsidiary. His new role includes an annual base salary of $60,000 under an executive employment agreement. Apimeds Pharmaceuticals US, Inc. operates in the pharmaceutical industry.
